+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Thoracic Surgery Market 2019-2023 - Product Image

Global Thoracic Surgery Market 2019-2023

  • ID: 4792970
  • Report
  • June 2019
  • Region: Global
  • 152 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp.
  • LivaNova Plc
  • Medtronic Plc
  • MORE
Global Thoracic Surgery Market: About this market

Thoracic surgery is an operation performed for treating conditions of the chest organs, including the heart, lungs, esophagus, and trachea. This thoracic surgery market analysis considers the revenues generated from products such as CRM and cardiac assist devices, heart valve repair and replacement devices, cardiopulmonary devices, heart defect closure devices, and other thoracic surgery devices. Our analysis also considers the sales of thoracic surgery in North America, Europe, Asia, and ROW. In 2018, the CRM and cardiac assist devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of cardiac arrhythmia will play a significant role in the CRM and cardiac assist devices segment to maintain its market position. Our global thoracic surgery market report looks at factors such as the increasing prevalence of CVDs and lung diseases, growing awareness initiatives and access to healthcare, and technological advances and new product launches. However, the high cost of thoracic surgeries and devices, stringent regulations, and shortage of skilled thoracic surgeons may hamper the growth of the thoracic surgery industry over the forecast period.

Global thoracic surgery market: Overview

Technological advances and new product launches

The global thoracic surgery market is witnessing several technological advancements in both MI surgeries and open procedures. Technological advancements in endoscopy have led to the development of ultra-MI thoracic procedures, which can be performed on patients with the benign esophageal disease and early-stage esophageal cancer. Thus, significant advances in devices will fuel the demand for thoracic surgeries, thereby, driving the growth of the market at a CAGR of more than 9% during the forecast period.

Increasing number of thoracic surgeries

The demand for thoracic surgeries has increased significantly among patients with severe comorbid conditions. This is mainly due to technological advancements in thoracic surgery devices along with improved experience and confidence of surgeons to operate on high-risk individuals. Furthermore, the increase recommendations by health organizations promoting the use of these devices are also propelling the demand for thoracic surgery. Thus, the increasing number of thoracic surgeries is identified as a key trend that will impact the growth of the market during the forecast period.

Competitive Landscape

With the presence of few major players, the global thoracic surgery market is concentrated. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading thoracic surgery providers, that include Abbott Laboratories, Boston Scientific Corp., Edwards Lifesciences Corp., LivaNova Plc, and Medtronic Plc.

Also, the thoracic surgery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp.
  • LivaNova Plc
  • Medtronic Plc
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • CRM and cardiac assist devices - Market size and forecast 2018-2023
  • Heart valve repair and replacement devices
  • Market size and forecast 2018-2023
  • Cardiopulmonary devices - Market size and forecast 2018-2023
  • Heart defect closure devices - Market size and forecast 2018-2023
  • Other thoracic surgery devices - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Strategic acquisitions
  • Increasing number of thoracic surgeries
  • Increasing focus on robotic surgeries
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Boston Scientific Corp.
  • Edwards Lifesciences Corp.
  • LivaNova Plc
  • Medtronic Plc
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: CRM and cardiac assist devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: CRM and cardiac assist devices - Year-over-year growth 2019-2023 (%)
Exhibit 21: Heart valve repair and replacement devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Heart valve repair and replacement devices - Year-over-year growth 2019-2023 (%)
Exhibit 23: Cardiopulmonary devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Cardiopulmonary devices - Year-over-year growth 2019-2023 (%)
Exhibit 25: Heart defect closure devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Heart defect closure devices - Year-over-year growth 2019-2023 (%)
Exhibit 27: Other thoracic surgery devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Other thoracic surgery devices - Year-over-year growth 2019-2023 (%)
Exhibit 29: Market opportunity by product
Exhibit 30: Customer landscape
Exhibit 31: Market share by geography 2018-2023 (%)
Exhibit 32: Geographic comparison
Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: North America - Year-over-year growth 2019-2023 (%)
Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Cardiac devices new implant rates per 100,000 population between 2010 and 2015
Exhibit 45: Number of CABG procedures performed between 2010 and 2016 in various countries
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: Abbott Laboratories - Vendor overview
Exhibit 52: Abbott Laboratories - Business segments
Exhibit 53: Abbott Laboratories - Organizational developments
Exhibit 54: Abbott Laboratories - Geographic focus
Exhibit 55: Abbott Laboratories - Segment focus
Exhibit 56: Abbott Laboratories - Key offerings
Exhibit 57: Abbott Laboratories - Key customers
Exhibit 58: Boston Scientific Corp. - Vendor overview
Exhibit 59: Boston Scientific Corp. - Business segments
Exhibit 60: Boston Scientific Corp. - Organizational developments
Exhibit 61: Boston Scientific Corp. - Geographic focus
Exhibit 62: Boston Scientific Corp. - Segment focus
Exhibit 63: Boston Scientific Corp. - Key offerings
Exhibit 64: Boston Scientific Corp. - Key customers
Exhibit 65: Edwards Lifesciences Corp. - Vendor overview
Exhibit 66: Edwards Lifesciences Corp. - Product segments
Exhibit 67: Edwards Lifesciences Corp. - Organizational developments
Exhibit 68: Edwards Lifesciences Corp. - Geographic focus
Exhibit 69: Edwards Lifesciences Corp. - Segment focus
Exhibit 70: Edwards Lifesciences Corp. - Key offerings
Exhibit 71: Edwards Lifesciences Corp. - Key customers
Exhibit 72: LivaNova Plc - Vendor overview
Exhibit 73: LivaNova Plc - Business segments
Exhibit 74: LivaNova Plc - Organizational developments
Exhibit 75: LivaNova Plc - Geographic focus
Exhibit 76: LivaNova Plc - Segment focus
Exhibit 77: LivaNova Plc - Key offerings
Exhibit 78: LivaNova Plc - Key customers
Exhibit 79: Medtronic Plc - Vendor overview
Exhibit 80: Medtronic Plc - Business segments
Exhibit 81: Medtronic Plc - Organizational developments
Exhibit 82: Medtronic Plc - Geographic focus
Exhibit 83: Medtronic Plc - Segment focus
Exhibit 84: Medtronic Plc - Key offerings
Exhibit 85: Medtronic Plc - Key customers
Exhibit 86: Validation techniques employed for market sizing
Exhibit 87: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp.
  • LivaNova Plc
  • Medtronic Plc
  • MORE
The following companies are recognised as the key players in the global thoracic surgery market: Abbott Laboratories, Boston Scientific Corp., Edwards Lifesciences Corp., LivaNova Plc, and Medtronic Plc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing number of thoracic surgeries.”

According to the report, one of the major drivers for this market is the technological advances and new product launches.

Further, the report states that one of the major factors hindering the growth of this market is the shortage of skilled thoracic surgeons.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott Laboratories
  • Boston Scientific Corp.
  • Edwards Lifesciences Corp.
  • LivaNova Plc
  • Medtronic Plc
Note: Product cover images may vary from those shown
Adroll
adroll